India's GlaxoSmithKline Pharma gains on Q2 profit growth
** Shares of GlaxoSmithKline Pharma GLAX.NS rise 2% to
2,682 rupees
** The pharma co posted a 15% uptick in Q2 consol profit
before tax to 3.44 bln rupees (~$41 mln)
** Rev for ops grew 5.6%, driven by strong demand for its
generic drugs and vaccines
** Stock up 41% so far this year
($1 = 84.0770 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees